Exane BNP Paribas cuts Maire to 'neutral' on limited upside

Maire SpA

11/05/2026 11:44

** Exane BNP Paribas cuts Italy's Maire MTCM.MI to "neutral" from "buy," saying that the stock is now trading close to its main peers and offers limited upside

** It expects Maire's order intake momentum to stay "healthy" but with little upside potential until 2027

** With the 9 billion euros ($10.59 billion) intake expected already for 2026, giga projects are likely to come in 2027 or later, BNP Paribas says

** In its view another year of strong growth may be difficult to achieve, and hence it sees "only" single-digit EPS organic growth

** While Nextchem IPO is a key potential catalyst, it is unlikely in the short term, the brokerage adds

** It ups PT by 14% to 16 euros, with the stock currently trading around 15.6 euros after rising 17.9% YTD

** Out of eight analysts that cover the group, six rate the stock "strong buy" or "buy," ​one rate it "hold" and one rate it "sell" - LSEG data

($1 = 0.8495 euros)

 (Reporting by Anna Uras)

 ((Anna.uras@thomsonreuters.com))